M Zuehlsdorf
Overview
Explore the profile of M Zuehlsdorf including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
10
Citations
127
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Jensen J, Scherer A, Wanke C, Brautigam M, Bongiovanni S, Letzkus M, et al.
Allergy
. 2011 Dec;
67(3):413-23.
PMID: 22142306
Background: Topical corticosteroids and calcineurin inhibitors are well-known treatments of atopic dermatitis (AD) but differ in their efficacy and side effects. We recently showed that betamethasone valerate (BM) although clinically...
2.
Thoennissen N, Schliemann C, Hungermann D, Bremer J, Juergens K, Semik M, et al.
Ann Hematol
. 2007 Oct;
87(5):417-20.
PMID: 17932670
No abstract available.
3.
Mueck W, Becka M, Kubitza D, Voith B, Zuehlsdorf M
Int J Clin Pharmacol Ther
. 2007 Jun;
45(6):335-44.
PMID: 17595891
Objective: Rivaroxaban (BAY 59-7939) is an oral, direct Factor Xa (FXa) inhibitor being developed for the prevention and treatment of thromboembolic disorders. This analysis aimed to define population models for...
4.
Scheffold C, Kroeger M, Zuehlsdorf M, Tchinda J, Silling G, Bisping G, et al.
Leukemia
. 2004 Oct;
18(12):2048-50.
PMID: 15470491
No abstract available.
5.
Cassens U, Momkvist P, Zuehlsdorf M, Mohr M, Kienast J, Berdel W, et al.
Bone Marrow Transplant
. 2001 Aug;
28(1):13-20.
PMID: 11498739
Although several studies have demonstrated the efficacy of large volume leukapheresis (LVL) to yield high numbers of peripheral blood progenitor cells (PBPC), the mechanisms of stem cell release into circulation...
6.
Westermann F, Kube D, Haier B, Bohlen H, Engert A, Zuehlsdorf M, et al.
Ann Oncol
. 1996 Apr;
7(4):397-404.
PMID: 8805932
Background: Unlike normal hematopoietic cells leukemic blasts from patients with AML constitutively express cytokines like IL1, GM-CSF and TNF alpha and it has been suggested that these cytokines may regulate...
7.
Buechner T, Hiddemann W, Koenigsmann M, Zuehlsdorf M, Woermann B, Boeckmann A, et al.
Bone Marrow Transplant
. 1990 Jul;
6 Suppl 1:131-4.
PMID: 2202465
Chemotherapy (CT) induced critical neutropenia remains a major dose limiting problem in acute leukemias. In order to reduce the phase of risk we gave recombinant human GM-CSF to 30 patients...
8.
Buchner T, Hiddemann W, Koenigsmann M, Zuehlsdorf M, Woermann B, Boeckmann A, et al.
Haematol Blood Transfus
. 1990 Jan;
33:724-31.
PMID: 2182462
Chemotherapy (CT) induced critical cytopenia remains as the major dose limiting problem in the treatment of acute leukemias. This is especially true in patients at high risk of early death...
9.
Jones R, Zuehlsdorf M, Rowley S, Hilton J, SANTOS G, SENSENBRENNER L, et al.
Blood
. 1987 Nov;
70(5):1490-4.
PMID: 3311205
We examined the effects of varying incubation conditions on the in vitro activity of 4-hydroperoxycyclophosphamide (4HC). 4HC activity against CFU-GM and against the K562 tumor cell line decreased with increasing...
10.
Rowley S, Zuehlsdorf M, Braine H, COLVIN O, Davis J, Jones R, et al.
Blood
. 1987 Jul;
70(1):271-5.
PMID: 3297203
Autologous bone marrow transplants (BMTs) can repopulate the hematologic system of patients treated with marrow-ablative chemotherapy and/or radiotherapy. However, treatment of the bone marrow graft to eliminate residual tumor cells...